Projects per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Collaborations and top research areas from the last five years
Projects
- 1 Finished
-
Chararacterisation of Topical Delivery System for Follistatin Treatment of Fibrotic Skin Diseases
Temple-Smith, P. (Primary Chief Investigator (PCI)), Ham, J. (Chief Investigator (CI)), Southwick, G. J. (Chief Investigator (CI)) & de Kretser, D. (Chief Investigator (CI))
Australasian Foundation for Plastic Surgery Limited
1/01/17 → 31/12/18
Project: Research
-
Role of G protein-coupled receptor kinases (GRKs) in β2-adrenoceptor-mediated glucose uptake
Ham, S., Mukaida, S., Sato, M., Keov, P., Bengtsson, T., Furness, S., Holliday, N. D., Evans, B. A., Summers, R. J. & Hutchinson, D. S., Feb 2024, In: Pharmacology Research & Perspectives. 12, 1, 16 p., e1176.Research output: Contribution to journal › Article › Research › peer-review
Open Access -
The novel adrenergic agonist ATR-127 targets skeletal muscle and brown adipose tissue to tackle diabesity and steatohepatitis
Talamonti, E., Davegardh, J., Kalinovich, A., van Beek, S. M. M., Dehvari, N., Halleskog, C., Bokhari, H. M., Hutchinson, D. S., Ham, S., Humphrys, L. J., Dijon, N. C., Motso, A., Sandstrom, A., Zacharewicz, E., Mutule, I., Suna, E., Spura, J., Ditrychova, K., Stoddart, L. A. & Holliday, N. D. & 11 others, , Jul 2024, In: Molecular Metabolism. 85, 16 p., 101931.Research output: Contribution to journal › Article › Research › peer-review
Open Access2 Citations (Scopus) -
Pharmacophore-guided Virtual Screening to Identify New β3-adrenergic Receptor Agonists
Ujiantari, N. S. O., Ham, S., Nagiri, C., Shihoya, W., Nureki, O., Hutchinson, D. S. & Schuster, D., Jul 2022, In: Molecular Informatics. 41, 7, 14 p., 2100223.Research output: Contribution to journal › Article › Research › peer-review
Open Access10 Citations (Scopus) -
Potential treatment of keloid pathogenesis with follistatin 288 by blocking the activin molecular pathway
Ham, S., Harrison, C., de Kretser, D., Wallace, E. M., Southwick, G. & Temple-Smith, P., Mar 2021, In: Experimental Dermatology. 30, 3, p. 402-408 7 p.Research output: Contribution to journal › Article › Research › peer-review
5 Citations (Scopus) -
The metabolic effects of mirabegron are mediated primarily by β3-adrenoceptors
Dehvari, N., Sato, M., Bokhari, M. H., Kalinovich, A., Ham, S., Gao, J., Nguyen, H. T. M., Whiting, L., Mukaida, S., Merlin, J., Chia, L. Y., Wootten, D., Summers, R. J., Evans, B. A., Bengtsson, T. & Hutchinson, D. S., 1 Oct 2020, In: Pharmacology Research & Perspectives. 8, 5, 16 p., e00643.Research output: Contribution to journal › Article › Research › peer-review
Open Access14 Citations (Scopus)